Samsung Bioepis Releases First Quarter 2026 US Biosimilar Market Report, Providing Updates to Evolving Drug Pricing Models

INCHEON, Korea--(BUSINESS WIRE)--Jan 23, 2026--

Samsung Bioepis Co., Ltd. today released its First Quarter 2026 Biosimilar Market Report, marking the twelfth edition of the Quarterly Biosimilar Market Report in the United States (US). The report provides an overview of the market status of all biosimilars available in the US, including approval and launch status, pricing (both Average Sales Price [ASP] and Wholesale Acquisition Cost [WAC]), and market uptake per molecule. The Deep Dive section in this edition provides an overview of the evolving US Pharmacy Benefit Manager (PBM) rebate contract model and how its frameworks may potentially impact the biosimilar market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260123492404/en/

“As the US healthcare market enters 2026, stakeholders’ approaches to prescription drug pricing and management continue to evolve. Alongside established PBM contracting structures, new models emphasizing alternative pricing reimbursement, transparency, and a shift towards more fiduciary responsibility have emerged in response to changing market conditions,” said Thomas Newcomer, Vice President, Head of US Commercial Operations, at Samsung Bioepis. “In this quarter’s report, we provide an overview of these developments and consider how evolving PBM rebate frameworks may influence utilization patterns, including potential implications for biosimilars.”

Key highlights from market analysis:

To access the First Quarter 2026 Samsung Bioepis Market Report, please visit HERE.

About Samsung Bioepis Co., Ltd.

Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biologic candidates that cover a spectrum of therapeutic areas, including immunology, oncology, ophthalmology, hematology, nephrology, and endocrinology. For more information, please visit: www.samsungbioepis.com and follow us on LinkedIn and X.

Samsung Bioepis released its First Quarter 2026 Biosimilar Market Report, providing an overview of the market status of all biosimilars available in the US.

EDINBURGH, Scotland (AP) — Celtic missed its chance to close the gap on Heart of Midlothian on Sunday after conceding late to draw 2-2 with the Scottish Premiership leader.

Claudio Braga's 87th-minute goal at Tynecastle Park leveled the game and kept first-place Hearts six points clear of the defending champion.

But the draw saw Rangers move up to second and within four points of Hearts with a 3-0 win against Dundee.

Hearts is the surprise leader in Scotland in a league that has long been dominated by Celtic and Rangers.

Celtic has lost two managers already this term — following the departure of Brendan Rodgers and the dismissal of Wilfried Nancy — and is being led by club icon Martin O'Neill on an interim basis for the second time this season.

Yet it remains in contention at the top and looked to pick up a vital win at Hearts when Yang Hyun-jun opened up a 2-1 lead in the 62nd.

But the visitors went down to 10 men when Auston Trusty was sent off 15 minutes later.

Hearts eventually made the numerical advantage count with Braga's equalizer.

Celtic had taken an early lead through Benjamin Nygren, but Stuart Findlay made it 1-1 just after halftime.

James Tavernier, Danilo and Djeidi Gassama struck in Rangers' win against Dundee at Ibrox, with two of those goals coming in time added on.

AP soccer: https://apnews.com/hub/soccer

Celtic's Benjamin Nygren battles for the ball with Heart of Midlothian's Claudio Braga, left, and Marc Leonard during the William Hill Premiership match in Edinburgh, Scotland, Sunday Jan. 25, 2026. (Jane Barlow/PA via AP)

Heart of Midlothian's Claudio Braga celebrates scoring their side's second goal of the game during the William Hill Premiership match in Edinburgh, Scotland, Sunday Jan. 25, 2026. (Jane Barlow/PA via AP)

Heart of Midlothian's Claudio Braga, second right, scores their side's second goal of the game during the William Hill Premiership match in Edinburgh, Scotland, Sunday Jan. 25, 2026. (Jane Barlow/PA via AP)